Skip to main content
SpringerLink
Log in

Drug Discovery and Development

Reflections and Projections

  • Chapter
Drug Discovery and Development

Abstract

The process of drug discovery involves a melding of many disciplines and interests, transcending the relatively simple process of identifying an active compound in the test tube. The discovery of a novel chemical entity that modulates some aspect of cell or tissue function is but the first step in the drug development process. Once shown to be selective and efficacious, a compound must also be relatively free of toxicity, bioavailable, and marketable before it can be considered to be a therapeutic entity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Albers-Schonberg, G., Arison, B.H., Hirshfield, J. M., and Hoogsteen, K. (1981) The absolute stereochemistry and conformation of Avermectin B2a aglycone and avermectin B1a. J. Amer. Chem. Soc. 103, 4221–4225.

    Article  Google Scholar 

  • Antonaccio, M. (1984) Cardiovascular Pharmacology 2nd Ed., Raven, New York.

    Google Scholar 

  • Badawy, M. K. (1985) Career advancement. Chem. Eng. News 63, 28–38.

    Article  Google Scholar 

  • Bartholini, G. (1983) Organization of Industrial Drug Research, in Decision Making In Drug Research ( Gross, F., ed.) Raven, New York.

    Google Scholar 

  • Bezold, C. (1983) Pharmaceuticals In The Year 2000. The Changing Context for Drug R & D. Institute for Alternative Futures, Alexandria, Virginia.

    Google Scholar 

  • Black, J. W. and Stephenson, J. S. (1962) Pharmacology of a new adrenergic beta-receptor-blocking compound (nethalide). Lancet ii, 311–314.

    Article  Google Scholar 

  • Black, J. YV., Duncan, W. A. M., Durant, C. J., Ganellin, C. R., and Parsons, E. M. (1972) Definition and antagonism of histamine H2 receptors. Nature 236, 385–390.

    Article  PubMed  CAS  Google Scholar 

  • Bodor, N. and Farag, A. H. (1983) Improved delivery through biological membranes 13. Brain specific delivery of dopamine with a dihydropyridine ⇋ pyridinium salt type redox delivery system. J. Med. Chem. 26, 528–534.

    Article  PubMed  CAS  Google Scholar 

  • Bradshaw, J., Brittain, R. T., Clitherow, J. W., Daly, M. J., Jack, D., Price, B. J., and Stables, R. (1979) AH 19065: A new potent, selective histamine H2 receptor antagonist. Br. J. Phannacol. 66, 464 p.

    Google Scholar 

  • Brodie, B. B. (1986) Apprentice to Genius. The Making of a Scientific Dynasty (Kanigel, R., ed.) Macmillan, New York.

    Google Scholar 

  • Campbell, W. C., Fisher, M. H., and Stapley, E. O. (1983) Ivermectin: A potent new antiparasitic agent. Science 221, 823–828.

    Article  PubMed  CAS  Google Scholar 

  • Casement, R. (1984) The Bug Business Becomes a Gold Rush, in Man Suddenly Sees To The Edge Of The Universe Open Court, La Salle, Illinois.

    Google Scholar 

  • Chang, R. S. L., Lotti, V. J., Monaghan, R. L., Birnbaum, J., Stapley, E. O., Gcotz, M. A., Albers-Schonberg, G., Patchett, A. A., Liesch, J. M., Hensens, O. D., and Springer, J. P. (1985) A potent non-peptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 230, 177–179.

    CAS  Google Scholar 

  • Charney, D. S., Menkes, D. B., and Heninger, G. R. (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch. Gen. Psychiat. 38, 1160–1180.

    PubMed  CAS  Google Scholar 

  • Clineschmidt, B. V., Mckendry, M. A., Papp, N. L., Pflueger. P. B., Stone, C. A., Totaro, J. A., and Williams, M. (1979) Stereospecific anti-dopaminergic and anticholinergic actions of the enantiomers of (±)-l-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-diben/o[a,d]-cyclohe;ten-5-vlidene)piperidine (CTC), a derivative of cyproheptadine. J. Pharmacol. Exp. Ther. 208, 460–467.

    PubMed  CAS  Google Scholar 

  • Clineschmidt, B. V., Williams, M., Witoslawski, J. J., Bunting, P. R., Risley, E. A., and Totaro, J. A. (1982) Restoration of shock-suppressed behavior by treatment with (+)-5-methyl-l0,ll dihydro-5H–dibenzo[a,d]cyclohepten 5,10-imine (MK 801), a substance with potent anticonvulsant, central sympathomimimetic and apparent anxiolytic properties. Drug Develop. Res. 2, 123–134.

    Article  CAS  Google Scholar 

  • Cook, L. P. and Davidson, A. B. (1973) Effect of Behaviorally Active Drugs in a Conflict-Punishment in Rats, in The Benzodiazapines ( Garrattini, S., Mussini, R., and Randall, L. O., eds.) Raven, New York.

    Google Scholar 

  • Creese, I. (1985) Receptor Binding as a Primary Drug Screen, in Neurotransmitter Receptor Binding (2nd Ed.) ( Yamamura, H. I., Enna, S. J., and Kuhar, M. J., eds.) Raven, New York.

    Google Scholar 

  • Cushman, D. W. and Ondetti, M. A. (1980) Inhibitors of angiotensin-converting enzyme. Prog. Med. Chem. 17, 43–104.

    Google Scholar 

  • Davies, L. P. (1985) Pharmacological studies on adenosine analogs isolated from marine organisms. Trends Pharmacol. Sci. 6, 143–146.

    Article  CAS  Google Scholar 

  • Dibner, M. D. (1985a) The changing pharmaceutical industry: Impacts of biotechnology. Trends Pharmacol. Sci. 6, 343–346.

    Article  Google Scholar 

  • Dibner, M. D. (1985b) Biotechnology in pharmaceuticals: The Japanese challenge. Science 229, 1230–1235.

    Article  PubMed  CAS  Google Scholar 

  • Economist (1985a) The medicine-men spend more to discover less. Economist 295 (7394), 93–94.

    Google Scholar 

  • Economist (1985b) The primrose path. Economist 295 (7391), 104.

    Google Scholar 

  • Fitzgerald, J. D. (1983) Reflections on Some Problems in the Management of Drug DiscoverY, in Decision Making in Drug Research ( Gross, F., ed.) Raven, New York.

    Google Scholar 

  • Fagg, G. E. and Foster, A. C. (1984) Acidic amino acid binding sites in mammalian neuronal membranes. Their characteristics and relationship to synaptic receptors. Brain Res. Rev. 7, 103–164.

    Article  Google Scholar 

  • Gavish, M., Goodman, R. R., and Snyder, S. H. (1982) Solubili/ed adenosine receptors in the brain; regulation by guanine nucleotides. Science 215, 1633–1635.

    Article  PubMed  CAS  Google Scholar 

  • Goodford, P.J. (1984) Drug design by the method of receptor fit. J. Med. Chem. 27, 557–564.

    Article  CAS  Google Scholar 

  • Hamner, C. E. (1982) Drug Development, CRC Press, Boca Raton, FL.

    Google Scholar 

  • Hopfinger, A.J. (1985) Computer-assisted drug design. J. Med. Chem. 28, 1133–1139.

    Article  PubMed  CAS  Google Scholar 

  • Howlett, D. R., Morris. H. M., and Nahorski, S. R. (1979) Anomalous properties of (3H) Spiperone binding sites in various areas of the rat limbic system. Mol. Pharmacol. 15, 506–514.

    PubMed  CAS  Google Scholar 

  • Humphray, J. M., Daly, M.J. and Stables, R. (1982) Inhibition of gastric acid secretion by AH 22216, a new long-lasting histamine H-2 receptor antagonist. Gut 23, A899.

    Google Scholar 

  • Jack, D. (1983) Project Teams in Pharmaceutical Research, in Decision Making in Drug Research ( Gross, F., ed.) Raven, New York.

    Google Scholar 

  • Kolata, G. (1985) Why do people get fat? Science 227, 1327–1328.

    Article  PubMed  CAS  Google Scholar 

  • Laduron, P. (1984) Criteria for receptor sites in binding studies. Biochem. Pharmacol. 33, 833–839.

    Article  PubMed  CAS  Google Scholar 

  • Langston, J. W., Ballard, P., Tetrud, J. W., and Irwin, I. (1983) Chronic Parkinsonism in humans due to product of meperidinc-analog synthesis. Science 219, 979–982.

    Article  PubMed  CAS  Google Scholar 

  • Lasch, C. (1978) The Culture Of Narcissism, American Life in an Age of Diminishing Expectations. Norton, New York.

    Google Scholar 

  • Martin, G. E., Williams, M., and Haubrich, D. R. (1982) A pharmacological comparison of TL-99 and 3-PPP with selected dopamine agonists. J. Pharmacol. Exp. Ther. 223, 298–304.

    PubMed  CAS  Google Scholar 

  • Maxwell, R. A. (1984) The state of the art of the science of drug discovery—an opinion. Drug Dev. Res. 4, 375–389.

    Article  CAS  Google Scholar 

  • Murphy, D. E., Schneider,J., Lehmann, J., and Williams, M. (1986) Binding of [3H]CPP (3(2-carboxypiperazin-4-yl)propyl-l-phosphonic acid): A selective high affinity ligand for N-methyl-D-aspartate receptors. Abst. Soc. Neurosci. 12, 21. 4.

    Google Scholar 

  • Patchett, A., Harris, E., Tristan, E., Wyvratt, M., Wu, M. T., Taub, D., Peterson, E., Ikeler, T., ten Broeke, J., Payne. L., Oneyka, D., Thorsett, E., Greenlee, W., Lohr, N., Maycock, A., Hoffsommer, R., Joshua, H., Ruyle, W., Rothrock, J., Aster, S., Robinson, F. M., Sweet, C. S., Ulm, E. H., Gross, D. M., Vassil, T. C., and Stone, C. A. (1980) A new class of angiotensin converting enzyme inhibitors. Nature 288, 280–283.

    Article  PubMed  CAS  Google Scholar 

  • Patel, J. B. and Malick, J. B. (1983) Neuropharmacology Profile of an Anxiolytic, in Anxiolytics—Neurochemical Behavioral and Clinical Perspectives ( Malick, J. B., Enna, S. J., and Yamamura, H. I., eds.) Raven, New York.

    Google Scholar 

  • Pendelton, R. G., Torchiana, M. L., Chung, C., Cook, P., Weise, S., and Clineschmidt, B. V. (1983) Studies on MK 208 (YM-1170) a new slowly dissociable H2 receptor antagonist. Arch. Int. Pharm. Ther. 266, 4–11.

    Google Scholar 

  • Pert, C. B. and Snyder, S. H. (1973) Properties of opiate receptor binding in rat brain. Proc. Natl. Acad. Sci. USA 70, 2243–2247.

    Article  PubMed  CAS  Google Scholar 

  • Pocock, S. J. (1983) Clinical Trials. A Practical Approach. Wiley, New York.

    Google Scholar 

  • Porsolt, R. D. (1981) Behavioral Despair, in Antidepressants—Neurochemical, Behavioral and Clinical Perspectives ( Enna, S.J., Malick, J. B., and Richelson, E., eds.) Raven, New York.

    Google Scholar 

  • Porter, C. C., Watson, L. S., Titus, D. C., Totaro, J. A., and Byer, S. S. (1962) Inhibition of dopa decarboxylase by the hydrazine analog of α-methyldopa. Biochem. Pharmacol. 11, 1067–1071.

    Article  PubMed  CAS  Google Scholar 

  • Raisman, R., Briley, M., and Langer, S. Z. (1980) Specific tricyclic antidepressant binding sites in rat brain characterized by high affinity 3H-imipramine binding. Eur. J. Pharmacol. 61, 363–370.

    Article  Google Scholar 

  • Sachs, G. (1984) Pump blockers and ulcer disease. N. Eng. J. Med. 310, 785–786.

    Article  CAS  Google Scholar 

  • Sanders, L. (1975) The Tomorrow File. Putnam, New York.

    Google Scholar 

  • Schwartz, H. (1983) Images of the Year 2000: Alternative Pharmaceutical Futures, in Pharmaceuticals In The Year 2000. The Changing Context for Drug R & D ( Bezold, C., ed.) Institute for Alternative Futures, Alexandria, Virginia.

    Google Scholar 

  • Sharif, N. (1984) Excitatory amino acid receptors. Handb. Neurochem. 6, 239–259.

    CAS  Google Scholar 

  • Snyder, S. H. (1975) Neurotransmitter and drug receptors in the brain. Biochem. Pharmacol. 24, 1371–1374.

    Article  CAS  Google Scholar 

  • Snyder, S. H. (1983) Neurotransmitter binding and drug discovery. J. Med. Chem. 26, 1667–1672.

    Article  PubMed  CAS  Google Scholar 

  • Snyder, S. H., Greenberg, D., and Yamamura, H. I. (1974) Antischizophrenic drugs and brain cholinergic receptors; affinity for muscarinic sites predicts extrapyramidal effects. Arch. Gen. Psych. 31, 58–61.

    CAS  Google Scholar 

  • Squires, R. F. and Braestrup, C. (1977) Benzodiazepine receptor in rat brain. Nature 266, 732–734.

    Article  PubMed  CAS  Google Scholar 

  • Stetler, C. J. (1985) An antidote for misconceptions. Pharm. Exec. 5, 54–55.

    Google Scholar 

  • Strittmatter, S. J., Lo, M. M. S., Javitch, J. A., and Snyder, S. H. (1984a) Autoradiographic visualization of antiotensin-converting enzyme in rat brain with [3H] captopril located to a striatonigral pathway. Proc. Natl. Acad. Sci. USA 81, 1599–1605.

    Article  PubMed  CAS  Google Scholar 

  • Strittmatter, S. J., Lynch, D. R., and Snyder, S. H. (1984b) [3H] Guandino ethylmercaptosuccinic acid binding to tissue homogenates. J. Biol. Chem. 259, 11812–11817.

    Google Scholar 

  • Sweet, C. S. and Blaine, E. H. (1984) Angiotensin-Converting Enzyme and Renin Inhibitors, in Cardiovascular Pharmacology (2nd Ed.) ( Antonaccio, M., ed.) Raven, New York.

    Google Scholar 

  • Testa, B. (1984) Drugs? Drug research? Advances in drug research? Musings of a medicinal chemist. Adv. Drug. Res. 13, 1–58.

    CAS  Google Scholar 

  • Tischler, M. and Denkewalter, R. G. (1966) Drug Research: Whence and Whither? in Progress in Drug Research ( Jucker, E., ed.) Basel, Switzerland.

    Google Scholar 

  • Topliss, J. (1983) Quantitative Structure—Activity Relationships Of Drugs, Academic, New York.

    Google Scholar 

  • Traina, V. M. (1983) The role of toxiology in drug research and development. Med. Res. Rev. 3, 43–72.

    Article  PubMed  CAS  Google Scholar 

  • Van Rooyen, J. M. and Offermeier, J. (1981) Peripheral dopaminergic receptors. Physiological and pharmaceutical aspects of therapeutic importance. S. Afr. J. med. 59, 329–332.

    Google Scholar 

  • Vogel, J. R. (1971) Antidepressants and Mouse Killing (Muricide) Behavior, in Antidepressants, Industrial Pharmacology vol. 2 (Fielding, S., and Lal, H., eds.) Futura, Mt. Kisco, New York.

    Google Scholar 

  • Williams, M. (1983) Anxioselective anxiolytics. J. Med. Chem. 26, 619–628.

    Article  PubMed  CAS  Google Scholar 

  • Williams, M. and Enna, S. J. (1986) The receptor: from concept to function. Ann. Rep. Med. Chem. 21, 211–235.

    Article  CAS  Google Scholar 

  • Williams, M. and U’Prichard, D. C. (1984) Drug discovery at the molecular level: A decade of radioligand binding in retrospect. Ann. Rep. Med. Chem. 19, 283–292.

    Article  CAS  Google Scholar 

  • Williams, M. and Wood. P. L. (1986) Receptor Binding as a Tool in Drug Screening and Evaluation. Neuromethods vol. 4 ( Boulton, A. A., Baker, G. B., and Hrdina, P., eds.) Humana, New Jersey.

    Google Scholar 

  • Williams, M., Jones, J. H., and Watling, K. J. (1983) Biochemical evaluation of the enatiomers of the novel ergoline 6-ethyl-9-oxaergoline (EOE). Drug Dev. Res. 3, 573–579.

    Article  CAS  Google Scholar 

  • Williams, M., Martin, G. E., Taylor, D. A., Yarbrough, G. G., Bendesky, R. J., King. S. W., Robinson, J. L., Totaro, J. A., and Clineschmidt, B. V. (1984) L-646, 462, a cyproheptadine related antagonist of dopamine and serotonin with selectivity for peripheral systems. J. Pharmacol. Exp. Ther. 229, 775–781.

    PubMed  CAS  Google Scholar 

  • Williams, W. (1985) Glory days end for pharmaceuticals. New York Times 24 February 1985, sec. 3, p. Fl.

    Google Scholar 

  • Yokoyama, N., Ritter, B., and Neubert, A. D. (1982) 2-Arylpyrazolo[4,3c) quinolin-3-ones: A novel agonist, a partial agonist and an antagonist of benzodiazepines. J. Med. Chem. 25, 337–339.

    Google Scholar 

Download references

Authors
  1. Michael Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey B. Malick
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Drug Discovery Administration, Pharmaceuticals Division, Ciba-Geigy Corporation, Summit, New Jersey, USA

    Michael Williams

  2. Biomedical Research Department, Stuart Pharmaceuticals, ICI Americas Inc., Wilmington, Delaware, USA

    Jeffrey B. Malick

Rights and permissions

Reprints and permissions

Copyright information

© 1987 The Humana Press Inc.

About this chapter

Cite this chapter

Williams, M., Malick, J.B. (1987). Drug Discovery and Development. In: Williams, M., Malick, J.B. (eds) Drug Discovery and Development. Humana Press. https://doi.org/10.1007/978-1-4612-4828-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4828-6_1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-4612-9180-0

  • Online ISBN: 978-1-4612-4828-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation